BLAINE WALSH: Open Payments
NPI 1598232951 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,453 in 93 payments from 17 companies in 2025. Trend: 2023 $1,327 · 2024 $1,447 · 2025 $3,453
Food & beverage: $2,242Travel & lodging: $1,211
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 16 | $1,801 |
| GlaxoSmithKline, LLC. | 18 | $262 |
| Axsome Therapeutics, Inc. | 10 | $213 |
| Verona Pharma, Inc. | 5 | $208 |
| AstraZeneca Pharmaceuticals LP | 10 | $202 |
| Regeneron Healthcare Solutions, Inc. | 6 | $138 |
| Grifols USA, LLC | 5 | $101 |
| HARMONY BIOSCIENCES LLC | 4 | $92 |
| Insmed, Inc. | 3 | $82 |
| JAZZ PHARMACEUTICALS INC. | 3 | $81 |
Products named: INSPIRE, NUCALA, DUPIXENT, Sunosi, Ohtuvayre, FASENRA, TEZSPIRE, WAKIX.
Industry payments across GA — which companies pay providers there.
